Communication to Shareholders - Intimation on Tax Deduction on Dividend

Corona Remedies Ltd has announced a recommended final dividend of ₹10 per share (100% on face value of ₹10) for FY 2025-26, subject to shareholder approval at the 22nd AGM. The Record Date for determining eligible shareholders is June 19, 2026. Under the Income Tax Act, 2025 (effective April 1, 2026), the company is required to deduct TDS on dividend payments at varying rates. For resident individual shareholders, TDS is NIL if dividend does not exceed ₹10,000 or if Form 121 is submitted; otherwise 10% (or 20% if PAN is invalid/missing). Non-resident shareholders/FPI face 20% TDS plus surcharge and cess, though beneficial tax treaty rates may apply if complete documentation is submitted. The deadline for submitting tax exemption documents to the RTA (Bigshare Services) is June 19, 2026. Dividend will be paid only via electronic mode.